InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the full record of transactions filed by Fischer Seth H. Z., Director. Director active across 4 companies, notably Agile Therapeutics INC. In total, 8 disclosures have been recorded. Total volume traded: €4k. The latest transaction was disclosed on 21 June 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
€4,2565,711 shares@ €0.7453100.0% of flow
Common Stock, $0.001 par value
SEC:0001209191-22-038810:0·
0670 shares0
Common Stock
SEC:0001104659-22-070181:0·
02,750 shares0
Common Stock
SEC:0001104659-22-012784·
02,750 shares0
Common Stock
SEC:0001104659-22-012784:0·
014,277 shares0
Common Stock, $0.001 par value
SEC:0001209191-21-042453·
014,277 shares0
Common Stock, $0.001 par value
SEC:0001209191-21-042453:0·
024,510 shares0
Common Stock
SEC:0001104659-21-079621·
024,510 shares0
Common Stock
SEC:0001104659-21-079621:0·
8 of 8 declarations
About Fischer Seth H. Z.
Seth H. Z. Fischer is a Director at AGILE THERAPEUTICS INC, SPECTRUM PHARMACEUTICALS INC, and MARINUS PHARMACEUTICALS INC. In this role, he contributes to the governance and strategy of these companies. His expertise in the biopharmaceutical sector is valuable in guiding research and development initiatives. As a director, he ensures that best practices are followed and that shareholder interests are protected.
